4//SEC Filing
Treacy Paul 4
Accession 0001232524-18-000154
CIK 0001232524other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 7:03 PM ET
Size
9.1 KB
Accession
0001232524-18-000154
Insider Transaction Report
Form 4
Treacy Paul
SVP, Technical Operations
Transactions
- Sale
Ordinary Shares
2018-08-10$176.61/sh−1,309$231,183→ 17,458 total
Footnotes (3)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.61 to $177.061. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F3]Includes 126 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2018.
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001615763
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 7:03 PM ET
- Size
- 9.1 KB